The proposed acquisition of Pharmaceutical Strategies (PS) represents a significant strategic move for Empresaria, providing exposure to the niche PBM sector within the fast-growing US healthcare staffing market, building the temporary staffing proportion of revenues within the group and enhancing earnings from FY16. We have increased our earnings estimate by 5% that year placing the shares on a FY16 rating 8.1x. We stand by our investment case that the shares are meaningfully undervalued and
13 Oct 2015
Proposed acquisition of PS Group
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Proposed acquisition of PS Group
Empresaria Group plc (EMR:LON) | 36.5 0.4 2.8% | Mkt Cap: 18.2m
- Published:
13 Oct 2015 -
Author:
Ben Thefaut -
Pages:
7
The proposed acquisition of Pharmaceutical Strategies (PS) represents a significant strategic move for Empresaria, providing exposure to the niche PBM sector within the fast-growing US healthcare staffing market, building the temporary staffing proportion of revenues within the group and enhancing earnings from FY16. We have increased our earnings estimate by 5% that year placing the shares on a FY16 rating 8.1x. We stand by our investment case that the shares are meaningfully undervalued and